Releuko Injection, Solution
Product Images NDC 70121-1571

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Releuko (NDC 70121-1571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Releuko Filgrastim Ayow Injection 1

RELEUKO (filgrastim) injection label by Amneal Pharmaceuticals LLC features the product name with pronunciation and generic name, accompanied by the Amneal logo above and a barcode below. The image presents clear branding and product identification elements.*

FDA Label Image

Releuko Filgrastim Ayow Injection 10

An instructional diagram showing how to set a partial dose on a syringe for RELEUKO (filgrastim) injection. It highlights lines related to dose amounts (0.3, 0.4, 0.5 mL), the top edge of the plunger stopper in initial and adjusted positions, and includes a hand pressing the syringe plunger slowly.*

FDA Label Image

Releuko Filgrastim Ayow Injection 11

Illustration showing a hand holding a syringe with a needle positioned above the skin of an arm, demonstrating the injection process likely related to the subcutaneous or intravenous administration of the drug.*

FDA Label Image

Releuko Filgrastim Ayow Injection 12

An instructional illustration showing the proper angles for injecting a solution subcutaneously. The image depicts a hand holding a syringe poised to inject into the skin at two angles: 45 degrees and 90 degrees.*

FDA Label Image

Releuko Filgrastim Ayow Injection 13

Instructional illustration showing a hand holding a syringe for injection. The images depict the step of preparing the syringe for subcutaneous or intravenous injection, including a close-up detail of the syringe plunger mechanism.*

FDA Label Image

Releuko Filgrastim Ayow Injection 14

An instructional illustration showing two steps of using a prefilled syringe. Both images depict a hand holding the syringe with a finger pressing the plunger and an arrow pointing upwards, indicating the action of pulling back or removing a component from the syringe before injection.*

FDA Label Image

Releuko Filgrastim Ayow Injection 15

An instructional illustration showing a hand placing a used syringe into a red sharps container. The container is labeled 'SHARPS CONTAINER' and is designed for safe disposal of needles and other sharp medical instruments.*

FDA Label Image

Releuko Filgrastim Ayow Injection 16

An instructional illustration showing components of a vial and a disposable syringe used for injection. The syringe parts labeled include the needle cap, syringe barrel with markings, and plunger. Additional elements such as a medication packet, tablet, and a red container with an open lid are also depicted.*

FDA Label Image

Releuko Filgrastim Ayow Injection 17

An instructional illustration showing hands holding a vial, demonstrating how to remove the metal cap by lifting the tab. The image depicts the steps for preparing an injection vial, relevant to injectable drugs like RELEUKO (Filgrastim).*

FDA Label Image

Releuko Filgrastim Ayow Injection 18

An instructional illustration showing hands removing the cap from a syringe. Inset shows a hand disposing of the discarded cap into a red sharps container with a flip top lid. The image demonstrates proper syringe cap removal and disposal technique.*

FDA Label Image

Releuko Filgrastim Ayow Injection 19

An instructional illustration showing hands withdrawing liquid from a vial using a syringe. The vial is held steady by one hand while the other hand pushes the syringe plunger down, indicated by a downward arrow, demonstrating how to extract the medication solution.*

FDA Label Image

Releuko Filgrastim Ayow Injection 2

An instructional diagram showing a syringe labeled with components before and after use. Parts identified include the gray needle cap, medicine window with markings, clear safety guard, syringe barrel, plunger stopper, finger grips, needle guard wings, plunger rod, plunger head, and label with expiration date. The after-use section shows the gray needle cap removed, the clear safety guard extended, and the used plunger rod.*

FDA Label Image

Releuko Filgrastim Ayow Injection 20

Illustration showing a pair of hands drawing liquid from a vial into an insulin syringe. The vial is held upside down, while the syringe is gradually filled by pulling the plunger. There are no visible labels on the vial or syringe in the image.*

FDA Label Image

Releuko Filgrastim Ayow Injection 21

An instructional illustration showing hands preparing an injection by drawing liquid from a vial into a syringe. One hand holds the vial and syringe, while the other hand appears to be flicking the syringe barrel to remove air bubbles. This image demonstrates proper injection preparation technique.*

FDA Label Image

Releuko Filgrastim Ayow Injection 22

An instructional illustration showing the recommended injection sites for RELEUKO (Filgrastim) solution. The front view highlights the upper arm, stomach area (abdomen), and thigh as injection sites. The rear view shows the upper arm and buttocks areas. Gray shaded regions indicate the specific locations for injection administration.*

FDA Label Image

Releuko Filgrastim Ayow Injection 23

An instructional illustration showing a person pinching the skin on the abdomen with two fingers, demonstrating proper technique for subcutaneous injection. The image includes arrows indicating the direction of the pinch.*

FDA Label Image

Releuko Filgrastim Ayow Injection 24

An instructional illustration showing proper subcutaneous injection technique. It depicts a syringe held at a 90-degree angle to the skin, with a smaller inset diagram showing the possible angle range from 45 to 90 degrees for injection.*

FDA Label Image

Releuko Filgrastim Ayow Injection 25

An instructional illustration depicting the subcutaneous injection technique. One hand holds a syringe with the needle positioned at the skin on the other hand, with a downward arrow indicating insertion of the needle into the skin.*

FDA Label Image

Releuko Filgrastim Ayow Injection 26

An instructional illustration showing a hand holding a syringe above a red disposal container, with an arrow indicating the syringe is being placed into the container for safe disposal. This image relates to proper disposal of injection equipment for RELEUKO (filgrastim) injectable solution.*

FDA Label Image

Releuko Filgrastim Ayow Injection 27

RELEUKO (filgrastim-ayow) Injection 300 mcg/0.5 mL single-dose prefilled syringes packaging label. The label indicates 10 prefilled syringes with a needle guard. Manufactured by Kashiv BioSciences, LLC and distributed by Amneal Pharmaceuticals LLC. The label includes the NDC number 70121-1568-7 and dosage form as injection solution with intravenous and subcutaneous routes.*

FDA Label Image

Releuko Filgrastim Ayow Injection 28

Packaging label for RELEUKO (filgrastim-ayow) Injection, 300 mcg/0.5 mL. The label indicates this is a single-dose prefilled syringe with a needle guard. The labeler is Amneal Pharmaceuticals LLC, and the product is described as a recombinant granulocyte colony stimulating factor (rG-CSF) derived from E. coli. Storage instructions and a list of inactive ingredients appear on the label along with NDC 70121-1568-1.*

FDA Label Image

Releuko Filgrastim Ayow Injection 29

Label for RELEUKO (filgrastim-ayow) Injection, a 300 mcg/0.5 mL single-dose prefilled syringe with needle guard. This subcutaneous injection solution is distributed by Amneal Pharmaceuticals LLC. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F), with warnings not to freeze or shake the product. The label includes the NDC 70121-1568-1 and a barcode.*

FDA Label Image

Releuko Filgrastim Ayow Injection 3

An instructional illustration showing hands manipulating a device with labeled parts: a plunger rod and a clear safety guard, likely part of an injection system. The diagram is intended to demonstrate a step in the use or preparation of an injection device.*

FDA Label Image

Releuko Filgrastim Ayow Injection 30

Releuko (filgrastim-ayow) Injection 300 mcg/0.5 mL single-dose prefilled syringe label for subcutaneous use. The label includes volume markings up to 0.5 mL, U.S. license number, Amneal Pharmaceuticals LLC as the labeler, and a barcode. The NDC is 70121-1568-1.*

FDA Label Image

Releuko Filgrastim Ayow Injection 31

Box label for RELEUKO (filgrastim-ayow) Injection 480 mcg/0.8 mL, a solution for injection. The label shows that the package contains 10 single-dose prefilled syringes with needle guards. It is manufactured by Kashiv BioSciences, LLC and distributed by Amneal Pharmaceuticals LLC. The label includes storage instructions and lists inactive ingredients.*

FDA Label Image

Releuko Filgrastim Ayow Injection 32

Releuko (filgrastim-ayow) Injection 480 mcg/0.8 mL carton label displays a single-dose prefilled syringe with needle guard. It is indicated for subcutaneous use, and the carton includes storage instructions to refrigerate at 2° to 8°C, with no freezing or shaking. Manufactured by Kashiv BioSciences, LLC and distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

Releuko Filgrastim Ayow Injection 33

Label for RELEUKO (filgrastim-ayow) Injection, 480 mcg/0.8 mL, a single-dose prefilled syringe with needle guard. The label states the drug is a recombinant granulocyte colony stimulating factor (rG-CSF) derived from E. coli, for subcutaneous use only. It includes storage instructions to refrigerate at 2° to 8°C and warnings against freezing and shaking. Distributed by Amneal Pharmaceuticals LLC, with NDC 70121-1570-1.*

FDA Label Image

Releuko Filgrastim Ayow Injection 34

Label for Releuko (filgrastim-ayow) injection, 480 mcg/0.8 mL dosage form, presented as a single-dose prefilled syringe for subcutaneous use only. The label includes the NDC 70121-1570-1, Amneal Pharmaceuticals LLC as the labeler, lot and expiration date fields, a barcode, and dosage volume markings from 0.1 to 0.8 mL.*

FDA Label Image

Releuko Filgrastim Ayow Injection 35

Carton label for RELEUKO (filgrastim-ayow) Injection, 300 mcg/mL. This human prescription drug injection solution is manufactured by Kashiv BioSciences, LLC and distributed by Amneal Pharmaceuticals LLC. The package contains 10 single-dose vials of 1 mL each. The label includes product name, strength, licensing, and manufacturer information with a clear dose strength marker of 300 mcg/mL.*

FDA Label Image

Releuko Filgrastim Ayow Injection 36

Label for Releuko (filgrastim-ayow) Injection 300 mcg/mL single-dose vial by Amneal Pharmaceuticals LLC. The label indicates use for subcutaneous or intravenous injection, includes the NDC 70121-1569-1, and states Rx only with a U.S. license number.*

FDA Label Image

Releuko Filgrastim Ayow Injection 37

Packaging label for RELEUKO (filgrastim-ayow) Injection 480 mcg/1.6 mL by Amneal Pharmaceuticals LLC. The label indicates 10 single-dose vials (1.6 mL each) with 480 mcg filgrastim per vial. It includes manufacturer information (Kashiv BioSciences, LLC) and storage instructions, with active ingredient details and prescribing information note.*

FDA Label Image

Releuko Filgrastim Ayow Injection 38

Releuko 480 mcg/1.6 mL injection solution label for a single-dose vial containing filgrastim (filgrastim-ayow) for subcutaneous or intravenous use. The label includes the NDC number 70121-1571-1 and is from Amneal Pharmaceuticals LLC. It features the Amneal logo and indicates the product is Rx only.*

FDA Label Image

Releuko Filgrastim Ayow Injection 4

An instructional diagram of a RELEUKO injection syringe showing labeled parts including a gray needle cap, a medicine window with volume markings, and the label area with expiration date. The syringe is designed for solution injection of Filgrastim by intravenous or subcutaneous routes.*

FDA Label Image

Releuko Filgrastim Ayow Injection 5

An instructional diagram displaying components for injection preparation, including an alcohol wipe, cotton ball, adhesive bandage, sharps disposal container, and a prefilled syringe labeled RELEUKO Filgrastim injection solution.*

FDA Label Image

Releuko Filgrastim Ayow Injection 6

An instructional diagram showing recommended injection sites on the human body. It highlights areas on the front including the upper arm, stomach (abdomen), and thigh, as well as the back areas including the upper arm and buttocks for injection placement.*

FDA Label Image

Releuko Filgrastim Ayow Injection 7

An instructional illustration showing a hand pulling straight off a needle cap from a syringe barrel, alongside a depiction of a syringe being disposed of into a labeled sharps container. The images depict the steps for safe needle removal and disposal.*

FDA Label Image

Releuko Filgrastim Ayow Injection 8

FDA Label Image

Releuko Filgrastim Ayow Injection 9

An instructional illustration showing a hand pressing the plunger of a prefilled syringe labeled RELEUKO, a filgrastim injection. The syringe is positioned vertically with the needle pointing upward, indicating how to properly operate the syringe for intravenous or subcutaneous administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.